According to the Associated Press, a Brazilian Supreme Court judge opened a criminal investigation into President Jair Bolsonaro's response to allegations of possible corruption in a health ministry contract to purchase 20 million (2 crore) doses of the coronavirus vaccine developed by India's Bharat Biotech.
Despite failing to gain regulatory approval, the comparably high pricing for Covaxin brought prosecutors' attention to the February sale. The Brazilian health ministry would have to pay $320 million (about Rs 2,375 crore) to Precisa Medicamentos, Bharat Biotech's middleman in Brazil, to purchase the vaccinations. As a result, each dose of Covaxin will set you around $15. (approximately Rs 1,100).
This was substantially more than the health ministry spent for Pfizer's vaccine, which had already received regulatory approval in the United States. According to sources, Bolsonaro also turned down Pfizer's offer to deliver vaccinations last year, repeatedly raising reservations about their usefulness.
The government suspended the contract on June 29 when suspicions of irregularities arose.